Piper Alderman advises PharmaLex on merger with specialist consultancy


Piper Alderman has successfully acted for PharmaLex Pty Ltd, on its merger with Cpharm Pty Ltd, a specialist consultancy providing pharmacovigilance, medical information and patient program services in Australia and New Zealand.

During this transaction, the global PharmaLex Group merged with AmerisourceBergen Corporation (see further details here).

The inclusion of Cpharm in the PharmaLex / AmerisourceBergen Group will expand PharmaLex’s service offering to the life sciences sector, growing its speciality services both in Australia and globally.

Grant Bennett, Managing Director of PharmaLex’s Australian division stated:

“Having worked with the Cpharm team for a number of years as specialist subcontractors, we are pleased to combine the businesses so as to provide a more comprehensive range of services to our clients. We were also glad to continue our collaboration with Piper Alderman as our Australian legal advisers, and draw on their deep experience of deals in the life sciences sector.”

The deal team led by partner Lis Boyce and supported by senior associate, Bahar Agar and lawyers, Francesca Lombardo and Samiha Asim, assisted PharmaLex with undertaking legal due diligence of Cpharm’s business operations and prepared the transaction documents for the acquisition of shares in Cpharm.

Commenting on the deal, Lis Boyce said:

“Having supported the local leadership team of PharmaLex through their own merger with PharmaLex GmbH in 2021, we were delighted to work with the global team of PharmaLex and AmerisourceBergen on this strategic transaction. “

Piper Alderman’s employment team led by Tim Capelin with support from associate, Emily Setter, was involved in preparing employment agreements for key employees of the Cpharm business.

Property partner, Marcus Andrews supported the deal with new lease documentation.

Related media coverage